Premier Biomedical Inc
OTC:BIEI
Income Statement
Earnings Waterfall
Premier Biomedical Inc
Income Statement
Premier Biomedical Inc
| Jun-2011 | Sep-2011 | Dec-2011 | Mar-2012 | Jun-2012 | Sep-2012 | Dec-2012 | Mar-2013 | Jun-2013 | Sep-2013 | Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | ||||||||||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+99%
|
0
+26%
|
0
+20%
|
0
-20%
|
0
-17%
|
0
-17%
|
0
-19%
|
0
-18%
|
0
-35%
|
|
| Gross Profit | ||||||||||||||||||||||||||||||||||||
| Cost of Revenue |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Gross Profit |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
+43%
|
0
-30%
|
0
N/A
|
0
-61%
|
(0)
N/A
|
(0)
-4%
|
(0)
+3%
|
(0)
-3%
|
0
N/A
|
|
| Operating Income | ||||||||||||||||||||||||||||||||||||
| Operating Expenses |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(4)
|
(4)
|
(5)
|
(4)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Selling, General & Administrative |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(4)
|
(4)
|
(5)
|
(4)
|
(2)
|
(2)
|
(1)
|
(1)
|
(2)
|
(3)
|
(3)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Operating Income |
(0)
N/A
|
(0)
-17%
|
(0)
-43%
|
(0)
-30%
|
(0)
+15%
|
(0)
-45%
|
(2)
-950%
|
(4)
-157%
|
(4)
-3%
|
(5)
-22%
|
(4)
+18%
|
(2)
+52%
|
(2)
N/A
|
(1)
+37%
|
(1)
-1%
|
(2)
-69%
|
(3)
-29%
|
(3)
+4%
|
(2)
+18%
|
(1)
+43%
|
(1)
+52%
|
(1)
-2%
|
(1)
+3%
|
(1)
+20%
|
(0)
+18%
|
(1)
-19%
|
(1)
-158%
|
(1)
0%
|
(1)
+1%
|
(1)
+12%
|
(1)
+39%
|
(1)
-1%
|
(1)
+1%
|
(1)
+2%
|
(0)
+52%
|
|
| Pre-Tax Income | ||||||||||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(6)
|
(7)
|
(3)
|
(2)
|
3
|
5
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Non-Reccuring Items |
0
|
0
|
(0)
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Pre-Tax Income |
(0)
N/A
|
(0)
-17%
|
(0)
-57%
|
(0)
-18%
|
(0)
+15%
|
(0)
-45%
|
(2)
-969%
|
(4)
-153%
|
(5)
-4%
|
(5)
-22%
|
(5)
+11%
|
(3)
+48%
|
(3)
N/A
|
(2)
+31%
|
(1)
+20%
|
(2)
-69%
|
(3)
-31%
|
(3)
+2%
|
(3)
+15%
|
(2)
+38%
|
(2)
N/A
|
(2)
-11%
|
(2)
+1%
|
(7)
-287%
|
(7)
-5%
|
(3)
+57%
|
(4)
-23%
|
2
N/A
|
3
+54%
|
(1)
N/A
|
(0)
+50%
|
(1)
-125%
|
(1)
-14%
|
(1)
+18%
|
(0)
+56%
|
|
| Net Income | ||||||||||||||||||||||||||||||||||||
| Tax Provision |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Income from Continuing Operations |
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(2)
|
(4)
|
(5)
|
(5)
|
(5)
|
(3)
|
(3)
|
(2)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(2)
|
(2)
|
(2)
|
(2)
|
(7)
|
(7)
|
(3)
|
(4)
|
2
|
3
|
(1)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Net Income (Common) |
(0)
N/A
|
(0)
-17%
|
(0)
-57%
|
(0)
-18%
|
(0)
+15%
|
(0)
-45%
|
(2)
-969%
|
(4)
-153%
|
(5)
-6%
|
(6)
-21%
|
(5)
+11%
|
(3)
+47%
|
(3)
+3%
|
(2)
+31%
|
(1)
+20%
|
(2)
-69%
|
(3)
-31%
|
(3)
+2%
|
(3)
+15%
|
(2)
+38%
|
(2)
N/A
|
(2)
-11%
|
(2)
+1%
|
(7)
-287%
|
(7)
-5%
|
(3)
+57%
|
(4)
-23%
|
2
N/A
|
3
+54%
|
(1)
N/A
|
(0)
+50%
|
(1)
-125%
|
(1)
-14%
|
(1)
+18%
|
(0)
+56%
|
|
| EPS (Diluted) |
-1.2
N/A
|
-1.4
-17%
|
-2.75
-96%
|
-2.6
+5%
|
-2.19
+16%
|
-3.2
-46%
|
-34.19
-968%
|
-72
-111%
|
-76.33
-6%
|
-92.5
-21%
|
-82.66
+11%
|
-32.87
+60%
|
-31.87
+3%
|
-22.12
+31%
|
-17.28
+22%
|
-26.44
-53%
|
-34.55
-31%
|
-33.88
+2%
|
-20.8
+39%
|
-4.59
+78%
|
-3.49
+24%
|
-2.71
+22%
|
-2.91
-7%
|
-4.24
-46%
|
-3.55
+16%
|
-1.51
+57%
|
-1.92
-27%
|
0
N/A
|
1.09
N/A
|
-0.24
N/A
|
-0.11
+54%
|
-0.12
-9%
|
-0.1
+17%
|
-0.03
+70%
|
-0.01
+67%
|
|